CAS: 1903008-80-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lazertinib REF: IN-DA01EB29CAS: 1903008-80-9 | 97% | 46.00 €~576.00 € | Wed 22 Jan 25 |
 | Lazertinib REF: TM-T4485CAS: 1903008-80-9 | 98.7% - 99.53% | 48.00 €~1,072.00 € | Wed 29 Jan 25 |
 | Lazertinib REF: TR-L215260CAS: 1903008-80-9 | - - - | 5,339.00 € | Tue 04 Mar 25 |
 | Lazertinib REF: 3D-DBD00880CAS: 1903008-80-9 | Min. 95% | 343.00 €~2,102.00 € | Wed 05 Mar 25 |
Lazertinib
CAS:1903008-80-9
Formula:
C30H34N8O3
Purity:
97%
Color and Shape:
Solid
Molecular weight:
554.6428
Ref: IN-DA01EB29
| 1mg | 46.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 102.00 € | ||
| 25mg | 176.00 € | ||
| 50mg | 214.00 € | ||
| 100mg | 481.00 € | ||
| 250mg | 576.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Lazertinib
CAS:1903008-80-9
Lazertinib (GNS-1480) is a potent, selective, irreversible EGFR-TKI; IC50: 1.7-76 nM for various EGFR mutations.
Formula:
C30H34N8O3
Purity:
98.7% - 99.53%
Color and Shape:
Solid
Molecular weight:
554.64
Ref: TM-T4485
| 1mg | 48.00 € | ||
| 5mg | 90.00 € | ||
| 10mg | 147.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 319.00 € | ||
| 100mg | 462.00 € | ||
| 500mg | 1,072.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
Lazertinib
Controlled ProductCAS:1903008-80-9
Formula:
C30H34N8O3
Color and Shape:
Neat
Molecular weight:
554.643
Ref: TR-L215260
| 500mg | 5,339.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
Lazertinib
CAS:1903008-80-9
Lazertinib is a potent tyrosine kinase inhibitor with inhibitory properties against cancer cells. Lazertinib has …
Formula:
C30H34N8O3
Purity:
Min. 95%
Molecular weight:
554.64 g/mol
Ref: 3D-DBD00880
| 5mg | 343.00 € | ||
| 10mg | 488.00 € | ||
| 25mg | 872.00 € | ||
| 50mg | 1,314.00 € | ||
| 100mg | 2,102.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
